SMAD4 and neoplasm: Previous studies [4–7] found that PDAC tumors have numerous somatic alterations that affect key oncogenic drivers and tumor suppressor genes including KRAS, TP53, CDKN2A and SMAD4, although it is still not clear which mutations lead to the acquisition of metastatic ability.